CoChat

Inhibition of carnitine biosynthesis by valproic acid in rats—The biochemical mechanism of inhibition

Farkas, Viktoria, Bock, Ildiko, Cseko, Joseph, Sandor, Attila · 1996 · Biochemical Pharmacology

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

The anticonvulsive drug, valproic acid (VPA), inhibits the biosynthesis of carnitine, and may contribute in this way to carnitine deficiency associated with VPA therapy. The conversion of [3H]-butyrobetaine into [3H]-carnitine was determined 60 min following a single intraperitoneal (i.p.) dose of 1.2 mmol/kg VPA in rats. The fraction of radioactivity found in [3H]-carnitine in the liver decreased from 63.2 +/- 1.50% to 39.2 +/- 1.11% (mean +/- SEM). Total carnitine in the liver also decreased, whereas the precursor butyrobetaine increased from 5.01 +/- 0.71 nmol/g to 8.22 +/- 0.82 nmol/g (mean +/- SEM). VPA also exhibited a dramatic effect on the conversion of an unlabeled loading amount of butyrobetaine. The increment in total carnitine caused by butyrobetaine in liver was reduced from 161 +/- 15.4 nmol/g to 53.2 +/- 5.11 nmol/g (mean +/- SEM). These data prove that VPA reduces the flux through butyrobetaine hydroxylase (EC 1.14.11.1.). The drug in vitro, however, did not inhibit the enzyme directly. Searching for the mechanism of action, we found that VPA decreased the level of alpha-ketoglutarate (alpha-KG; a cofactor of butyrobetaine hydroxylase) from 73.5 +/- 2.90 nmol/g to 52.9 +/- 2.2 nmol/g (mean +/- SEM) in the liver. The level of 1-glutamate showed a rather dramatic decrease in the liver. Moreover, alpha-KG proved to have a protective role against VPA in the [3H]-butyrobetaine conversion experiment.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0006-2952(96)00507-2

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 5

  1. Bohan, 1984, A novel metabolite of valproic acid, Ann Neurol, 16, 394
  2. Michal, 1974, vol. 4, 1967
  3. Michal, 1974, 2-Oxoglutarate, vol. 3, 1577
  4. Michal, 1974, L-glutamate. A., vol. 4, 1705
  5. Stadtman, 1957, Preparation and assay of acetyl-coenzyme A and other thiol esters; use of hydroxylamine, vol. 3, 931

Cited by

See all 49

Metadata

Authors
Farkas, V., Bock, I., Cseko, J., & Sandor, A.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
1996-11
Volume
52
Issue
9
Pages
1429-1433
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2071170489
Cited by
49
References
26
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 4 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 1 · 2012: 2
FWCI
1.84
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
valproic acid, carnitine biosynthesis, carnitine deficiency, alpha-ketoglutarate, liver, enzyme cofactors
MeSH terms
Acetyl Coenzyme A, Animals, Anticonvulsants, Betaine, Carnitine, Coenzyme A, Humans, Ketoglutaric Acids, Liver, Male, Valproic Acid, Rats, Wistar, Glutamic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of carnitine biosynthesis by valproic acid in rats—The biochemical mechanism of inhibition. https://app.cochat.ai/papers/10.1016/s0006-2952(96)00507-2
The paper
Farkas, V., Bock, I., Cseko, J., & Sandor, A. (1996). Inhibition of carnitine biosynthesis by valproic acid in rats—The biochemical mechanism of inhibition. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(96)00507-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.